{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T02:30:57Z","timestamp":1787452257361,"version":"build-2736575974"},"reference-count":36,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Acute respiratory distress syndrome (ARDS) is a serious inflammatory lung disorder and a complication of SARS-CoV-2 infection. In patients with severe SARS-CoV-2 infection, the transition to ARDS is principally due to the occurrence of a cytokine storm and an exacerbated inflammatory response. The effectiveness of ultra-micronized palmitoylethanolamide (PEA-um) during the earliest stage of COVID-19 has already been suggested. In this study, we evaluated its protective effects as well as the effectiveness of its congener, 2-pentadecyl-2-oxazoline (PEA-OXA), using in vitro models of acute lung injury. In detail, human lung epithelial cells (A549) activated by polyinosinic\u2013polycytidylic acid (poly-(I:C)) or Transforming Growth Factor-beta (TGF-\u03b2) were treated with PEA-OXA or PEA. The release of IL-6 and the appearance of Epithelial\u2013Mesenchymal Transition (EMT) were measured by ELISA and immunofluorescence assays, respectively. A possible mechanism of action for PEA-OXA and PEA was also investigated. Our results showed that both PEA-OXA and PEA were able to counteract poly-(I:C)-induced IL-6 release, as well as to revert TGF-\u03b2-induced EMT. In addition, PEA was able to produce an \u201centourage\u201d effect on the levels of the two endocannabinoids AEA and 2-AG, while PEA-OXA only increased PEA endogenous levels, in poly-(I:C)-stimulated A549 cells. These results evidence for the first time the superiority of PEA-OXA over PEA in exerting protective effects and point to PEA-OXA as a new promising candidate in the management of acute lung injury.<\/jats:p>","DOI":"10.3390\/biom13010033","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T04:40:39Z","timestamp":1672116039000},"page":"33","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury"],"prefix":"10.3390","volume":"13","author":[{"given":"Aniello","family":"Schiano Moriello","sequence":"first","affiliation":[{"name":"Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, 80078 Pozzuoli, Italy"},{"name":"Epitech Group SpA, Saccolongo, 35100 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorentina","family":"Roviezzo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Naples Federico II, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4480-8370","authenticated-orcid":false,"given":"Fabio Arturo","family":"Iannotti","sequence":"additional","affiliation":[{"name":"Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, 80078 Pozzuoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5420-395X","authenticated-orcid":false,"given":"Giuseppina","family":"Rea","sequence":"additional","affiliation":[{"name":"Microenvironment Molecular Targets, National Cancer Institute G. Pascale Foundation, IRCCS, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Allar\u00e0","sequence":"additional","affiliation":[{"name":"Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, 80078 Pozzuoli, Italy"},{"name":"Epitech Group SpA, Saccolongo, 35100 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Camerlingo","sequence":"additional","affiliation":[{"name":"Cellular Biology and Biotherapy-Research Department, National Cancer Institute G. Pascale Foundation, IRCCS, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Verde","sequence":"additional","affiliation":[{"name":"Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, 80078 Pozzuoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1490-3070","authenticated-orcid":false,"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[{"name":"Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, 80078 Pozzuoli, Italy"},{"name":"Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health, CRIUCPQ and INAF, Faculties of Medicine and Agriculture and Food Sciences, Universit\u00e9 Laval, Quebec City, QC G1V 4G5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Petrosino","sequence":"additional","affiliation":[{"name":"Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, 80078 Pozzuoli, Italy"},{"name":"Epitech Group SpA, Saccolongo, 35100 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5492\/wjccm.v1.i2.50","article-title":"Acute Respiratory Distress Syndrome and Lung Injury: Pathogenetic Mechanism and Therapeutic Implication","volume":"1","author":"Su","year":"2012","journal-title":"World J. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.21037\/atm.2017.06.62","article-title":"Definition and Epidemiology of Acute Respiratory Distress Syndrome","volume":"5","author":"Rezoagli","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.emc.2022.05.002","article-title":"Acute Respiratory Distress Syndrome","volume":"40","author":"Gragossian","year":"2022","journal-title":"Emerg. Med. Clin. North Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/can.2020.0043","article-title":"Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA","volume":"5","author":"Khodadadi","year":"2020","journal-title":"Cannabi. annabinoid. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"148517","DOI":"10.1172\/JCI148517","article-title":"Nasal Ciliated Cells Are Primary Targets for SARS-CoV-2 Replication in the Early Stage of COVID-19","volume":"131","author":"Ahn","year":"2021","journal-title":"J. Clin. Invest."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","article-title":"SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract","volume":"182","author":"Hou","year":"2020","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40246-022-00393-0","article-title":"From COVID to Fibrosis: Lessons from Single-Cell Analyses of the Human Lung","volume":"16","author":"Justet","year":"2022","journal-title":"Hum. Genomics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 Pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Petrosino, S., and Schiano Moriello, A. (2020). Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249526"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/bph.13580","article-title":"The Pharmacology of Palmitoylethanolamide and First Data on the Therapeutic Efficacy of Some of Its New Formulations","volume":"174","author":"Petrosino","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"C145","DOI":"10.1007\/BF01972748","article-title":"A Proposed Autacoid Mechanism Controlling Mastocyte Behaviour","volume":"39 Spec. No.","author":"Aloe","year":"1993","journal-title":"Agents Actions"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-Alpha Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide","volume":"67","author":"Fu","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The Orphan Receptor GPR55 Is a Novel Cannabinoid Receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj3580249","article-title":"Palmitoylethanolamide Inhibits the Expression of Fatty Acid Amide Hydrolase and Enhances the Anti-Proliferative Effect of Anandamide in Human Breast Cancer Cells","volume":"358","author":"Melck","year":"2001","journal-title":"Biochem. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12974-019-1671-5","article-title":"Palmitoylethanolamide Counteracts Substance P-Induced Mast Cell Activation in Vitro by Stimulating Diacylglycerol Lipase Activity","volume":"16","author":"Petrosino","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjp.2008.324","article-title":"\u201cEntourage\u201d Effects of N-Palmitoylethanolamide and N-Oleoylethanolamide on Vasorelaxation to Anandamide Occur through TRPV1 Receptors","volume":"155","author":"Ho","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-5793(01)02934-9","article-title":"Palmitoylethanolamide Enhances Anandamide Stimulation of Human Vanilloid VR1 Receptors","volume":"506","author":"Davis","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/bph.13084","article-title":"The Anti-Inflammatory Mediator Palmitoylethanolamide Enhances the Levels of 2-Arachidonoyl-Glycerol and Potentiates Its Actions at TRPV1 Cation Channels","volume":"173","author":"Petrosino","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","article-title":"Endocannabinoids and Endocannabinoid-Related Mediators: Targets, Metabolism and Role in Neurological Disorders","volume":"62","author":"Iannotti","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1098\/rstb.2012.0313","article-title":"Endocannabinoids in Nervous System Health and Disease: The Big Picture in a Nutshell","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1098\/rstb.2011.0391","article-title":"Mast Cell-Glia Axis in Neuroinflammation and Therapeutic Potential of the Anandamide Congener Palmitoylethanolamide","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phrs.2016.04.007","article-title":"2-Pentadecyl-2-Oxazoline: Identification in Coffee, Synthesis and Activity in a Rat Model of Carrageenan-Induced Hindpaw Inflammation","volume":"108","author":"Impellizzeri","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fphar.2017.00308","article-title":"2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation","volume":"8","author":"Petrosino","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9251","DOI":"10.1007\/s12035-018-1064-2","article-title":"2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease","volume":"55","author":"Cordaro","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1089\/neu.2016.4808","article-title":"N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury","volume":"34","author":"Impellizzeri","year":"2017","journal-title":"J. Neurotrauma"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"109130","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 Cytokine: An Overview of the Immune Regulation, Immune Dysregulation, and Therapeutic Approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rezaei Tolzali, M.M., Noori, M., Shokri, P., Rahmani, S., Khanzadeh, S., Nejadghaderi, S.A., Fazlollahi, A., Sullman, M.J.M., Singh, K., and Kolahi, A.-A. (2022). Efficacy of Tocilizumab in the Treatment of COVID-19: An Umbrella Review. Rev. Med. Virol., e2388.","DOI":"10.1002\/rmv.2388"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Del Re, A., Corpetti, C., Pesce, M., Seguella, L., Steardo, L., Palenca, I., Rurgo, S., De Conno, B., Sarnelli, G., and Esposito, G. (2021). Ultramicronized Palmitoylethanolamide Inhibits NLRP3 Inflammasome Expression and Pro-Inflammatory Response Activated by SARS-CoV-2 Spike Protein in Cultured Murine Alveolar Macrophages. Metabolites, 11.","DOI":"10.3390\/metabo11090592"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Albanese, M., Marrone, G., Paolino, A., Di Lauro, M., Di Daniele, F., Chiaramonte, C., D\u2019Agostini, C., Romani, A., Cavaliere, A., and Guerriero, C. (2022). Effects of Ultramicronized Palmitoylethanolamide (Um-PEA) in COVID-19 Early Stages: A Case-Control Study. Pharmaceuticals, 15.","DOI":"10.3390\/ph15020253"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-Regulated Endocannabinoids Are Involved in Maintaining Food Intake","volume":"410","author":"Goparaju","year":"2001","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The Endogenous Cannabinoid System Controls Extinction of Aversive Memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/bph.15754","article-title":"Sphingosine-1-Phosphate\/TGF-\u03b2 Axis Drives Epithelial Mesenchymal Transition in Asthma-like Disease","volume":"179","author":"Riemma","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Peritore, A.F., D\u2019Amico, R., Siracusa, R., Cordaro, M., Fusco, R., Gugliandolo, E., Genovese, T., Crupi, R., Di Paola, R., and Cuzzocrea, S. (2021). Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115533"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1465-9921-10-43","article-title":"Long-Term Activation of TLR3 by Poly(I:C) Induces Inflammation and Impairs Lung Function in Mice","volume":"10","author":"Stowell","year":"2009","journal-title":"Respir. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/cbdv.200790159","article-title":"The N-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA)","volume":"4","author":"Tsuboi","year":"2007","journal-title":"Chem. Biodivers."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.phrs.2016.07.010","article-title":"Ultramicronized Palmitoylethanolamide (PEA-Um(\u00ae)) in the Treatment of Idiopathic Pulmonary Fibrosis","volume":"111","author":"Impellizzeri","year":"2016","journal-title":"Pharmacol. Res."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/1\/33\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:50:13Z","timestamp":1760147413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/1\/33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["biom13010033"],"URL":"https:\/\/doi.org\/10.3390\/biom13010033","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,24]]}}}